| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| vs-5584 | target of rapamycin complex 2 mapkap1 | NA | Clinical trial target | TTD | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant mesothelioma[MeSHID:C562839] Malignant Neoplasms[MeSHID:D009369] |
NA | phase 1 | unknown |
| vs-5584 | serine/threonine-protein kinase mtor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant mesothelioma[MeSHID:C562839] Malignant Neoplasms[MeSHID:D009369] |
0.12 | phase 1 | unknown |
| vs-5584 | serine/threonine-protein kinase mtor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant mesothelioma[MeSHID:C562839] Malignant Neoplasms[MeSHID:D009369] |
0.12 | phase 1 | inhibitor |
| vs-5584 | pi3-kinase gamma | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant mesothelioma[MeSHID:C562839] Malignant Neoplasms[MeSHID:D009369] |
0.16 | phase 1 | inhibitor |
| vs-5584 | pi3-kinase gamma | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant mesothelioma[MeSHID:C562839] Malignant Neoplasms[MeSHID:D009369] |
0.16 | phase 1 | unknown |
| click here to return to the previous page | ||||||||